First International Electronic Conference on Synthetic Organic Chemistry (ECSOC-1), www.mdpi.org/ecsoc/, September 1-30, 1997
[A0039]

Synthesis of Optically Active n-Alkyloxycatechols as Inhibitors of Lipoxygenase

Mathias Juch and Peter Rüedi*

Institute of Organic Chemistry, University of Zurich,Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
Tel.: +41 1-2574241 Fax: +41 1-3619895, e-mail: peru@oci.unizh.ch, http://www.unizh.ch/oci/persons/ruedi.html

Received: 12 August 1997 / Uploaded: 15 August 1997

Abstract: Antioxidant activitv guided fractionation of extracts of Plectranthus sylvestris (labiatae) yielded the novel alkyloxycatechols 1-3 (M. Juch, P. Rüedi, Helv. Chim. Acta 1997, 80, 436). The optically active natural products and several diastereomers have been synthesized. The open chain compounds are prepared by enantioselsective reduction of the corresponding aldol adduct and chromatographic separation of the diastereomers, the cyclic ones by biomimetic phenol oxidation of 2b.

Apart from their antioxidative activity (similar to BHA and BHT), the catechols are in vitro inhibitors of lipoxygenase exhibiting IC50-values from the umol (1 und 2; similar to nordihydroguaiaretic acid and indomethacin) to the nmol range (3).


Introduction

In the course of our current research program concerning genuine constituents of African and Asian labiatae species with respect to antioxidants, inhibitors of the arachidonate metabolism and allergens [1][2], antioxidative activity guided fractionation of extracts of Plectranthus sylvestris (GÜRKE) yielded the novel optically active alkyloxycatechols 1-3 [2]. The compounds are inhibitors of Lipoxygenase (LO). With the aim to investigate the influence of the chirality and functionality in the side chain concerning the LO inhibition, enantio- and diastereomeric catechols of this type are being prepared.

Synthesis

The monoacetoxy compounds 2a and 2b have been prepared by enantioselective reduction of the aldol 4 followed by acetylation and selective saponification of the phenolic acetoxy groups. The tetrahydropyrans 1a and 1b were obtained from 5 and 2a/2b, resp. after biomimetic oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) [3]. The isomers 2a and 2b are separable by HPLC only after derivatization of the catechol moiety. In solution 2a and 2b undergo a slow 1,3-acyl shift (days) and the compounds can be oxidized with DDQ as a mixture which directly yields 1b. Due to the conformatively favourable arrangement of the substituents (all equatorial), the ring closure to the natural 2,4,6-trisubstituted tetrahydropyran is exclusively observed. Attempts to saponify selectively the corresponding triacetates of 6 resulted in an equilibrium mixture as a consequence of a fast 1,3-acyl shift.


Reduction with baker's yeast

without D-(+)-saccharose
with D-(+)-saccharose

Reduction with (S)-BINAP-Ru [4]
10bar/100deg.C
20 bar/75deg.C

Reaction time
4 days
7 days

Reaction time
3 hrs
20hrs

Transformation
100%
100%

Transformation
100%
100%

Yield 5; ee 5
27 %; 0.82
32%; 0.54

Yield 5; ee 5
60 %; 0.55
65%; 0.54

Yield 6; ee 6
27 %; 0.86
25 %; 0.26

Yield 6; ee 6
40 %; 0.88
35 %; 0.98

The ee-determinations of 5 were performed on the mixture of the triacetates 7a and 7b (the corresponding triacetates of 6, resp.) by HPLC on Chiralcel OD-H, 5u, 250x4.6 mm, hexane/2-propanol 9:1. This procedure enabled a simultaneous double determination.

The synthesis of the enantiomeric compounds ent-5 (3R,5R) and ent-6 (3S,5R) is in current progress.

Inhibition of Lipoxygenase

In order to get preliminary information concerning a structure-activity relationship for the inhibition of LO, compounds with variations of the configuration and functionality in the side chain have been tested. The activity of the enzyme ('Soybean Lipoxydase', Sigma, Type I-B) was monitored by a spectrophotometrical assay related to [5][6]. The IC50-values of the isolated alkyloxycatechols and of selected derivatives have been determined. The known anti-inflammatory and analgesic drugs nordihydroguaiaretic acid (NDGA) and indomethacin (INDO) were used as internal controls.



1a

1b
2a
2b
3
4
5
6
NDGA
INDO


IC50 [mM]
74
9
50
71
0.09
78
285
175
54
181

References

[1] Ch. Bürgi, P. Rüedi, Helv. Chim. Acta 1993, 76, 1890. [4] G. Capozzi, S. Roelens, S. Talami, J. Org. Chem. 1993, 58, 7932.

[2] M. Juch, P. Rüedi, Helv. Chim. Acta 1997, 80, 436. [5] J.C. Sircar, C.F. Schwender, E.A. Johnson, Prostaglandins 1983, 25, 393.

[3] Y. Oikawa, K. Horita, O. Yonemitsu, Heterocycles 1985, 23, 553. [6] A.T. Evans, E.A. Formukong, F.J. Evans, Biochem. Pharmacol. 1987, 36, 2035.


Comments

During 1-30 September 1997, all comments on this poster should be sent by e-mail to ecsoc@listserv.arizona.edu with A0039 as the message subject of your e-mail. After the conference, please send all the comments and reprints requests to the author(s).